Compliance With Post-Approval Commitments Goes Public On CDRH Web Site
This article was originally published in The Pink Sheet Daily
A Web site that will publicly display the status of FDA-required post-approval medical device studies will be operational within weeks, an agency staffer says.
You may also be interested in...
The high-profile COURAGE trial again raises the question of how soon stents should be placed in patients with coronary disease.
NIH and government agencies plan to submit plans to Congress next month describing ways to encourage the development of medical devices for children.
Do not be cavalier about this venue, drug/device lawyer warns.